國立虎尾科技大學 |

Molecular Determinants of Head and Neck Cancer

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Molecular Determinants of Head and Neck Cancer/ edited by Barbara Burtness, Erica A. Golemis.
其他作者:	Burtness, Barbara.
面頁冊數:	VI, 629 p. 68 illus., 62 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Cancer research. -
電子資源:	https://doi.org/10.1007/978-3-319-78762-6
ISBN:	9783319787626

Molecular Determinants of Head and Neck Cancer
Molecular Determinants of Head and Neck Cancer[electronic resource] /edited by Barbara Burtness, Erica A. Golemis. - 2nd ed. 2018. - VI, 629 p. 68 illus., 62 illus. in color.online resource. - Current Cancer Research,2199-2584. - Current Cancer Research,.

Squamous cell cancers of the head and neck (SCCHN), also known as head and neck cancers (HNC) encompass malignancies of the oral cavity, larynx, nasopharynx and pharynx, and are diagnosed in over 500,000 patients worldwide each year, accounting for 5% of all malignancies. It is estimated that approximately 50,000 patients develop head and neck cancer annually in the United States, of whom approximately 50% succumb to this cancer. For most cases of SCCHN, treatment is multimodal, often combining surgery or irradiation with chemotherapy; even successfully treated patients frequently experience durable and severe side effects. Improving cure rates and reducing chronic morbidity are urgent clinical needs for head and neck cancer. However, in contrast to cancer types such as breast or prostate that have been much studied and have well-defined biology, until recently, relatively few researchers investigated the molecular basis of HNC, making it difficult to design targeted treatments with better efficacy and less debilitating side effects. This volume will provide an overview of the factors contributing to disease pathogenesis, including the recognition of discrete molecular subtypes with distinct etiology, prognosis, and treatment response. This volume will familiarize the reader with the critical signaling pathways and oncogenic drivers for HNC. It will outline the differences between HPV-positive and HPV-negative disease, and how these differences affect treatment choice and outcome. The book will emphasize developments in the past five years, including the growing understanding of the genomic and epigenomic features of the disease based on analysis of next generation sequencing (NGS) data, and timely topics such as the analysis of HNC stem cell populations, non-coding mRNAs, and inflammatory response. It will address exciting new therapeutic approaches such as the use of immunotherapies to treat HNC patients. Overall, the book will provide the reader with current understanding of the biology and treatment of the disease, and describe timely questions that will guide future research aimed at controlling and curing this disease.

ISBN: 9783319787626

Standard No.: 10.1007/978-3-319-78762-6doiSubjects--Topical Terms:

1253664
Cancer research.

LC Class. No.: RC261-271

Dewey Class. No.: 614.5999

Molecular Determinants of Head and Neck Cancer
LDR:03543nam a22003975i 4500 001 989414
003 DE-He213
005 20200705125020.0
007 cr nn 008mamaa
008 201225s2018 gw | s |||| 0|eng d
020 $a 9783319787626 $9 978-3-319-78762-6
024 7 $a 10.1007/978-3-319-78762-6 $2 doi
035 $a 978-3-319-78762-6
050 4 $a RC261-271
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 614.5999 $2 23
245 1 0 $a Molecular Determinants of Head and Neck Cancer $h [electronic resource] / $c edited by Barbara Burtness, Erica A. Golemis.
250 $a 2nd ed. 2018.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Humana, $c 2018.
300 $a VI, 629 p. 68 illus., 62 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Current Cancer Research, $x 2199-2584
520 $a Squamous cell cancers of the head and neck (SCCHN), also known as head and neck cancers (HNC) encompass malignancies of the oral cavity, larynx, nasopharynx and pharynx, and are diagnosed in over 500,000 patients worldwide each year, accounting for 5% of all malignancies. It is estimated that approximately 50,000 patients develop head and neck cancer annually in the United States, of whom approximately 50% succumb to this cancer. For most cases of SCCHN, treatment is multimodal, often combining surgery or irradiation with chemotherapy; even successfully treated patients frequently experience durable and severe side effects. Improving cure rates and reducing chronic morbidity are urgent clinical needs for head and neck cancer. However, in contrast to cancer types such as breast or prostate that have been much studied and have well-defined biology, until recently, relatively few researchers investigated the molecular basis of HNC, making it difficult to design targeted treatments with better efficacy and less debilitating side effects. This volume will provide an overview of the factors contributing to disease pathogenesis, including the recognition of discrete molecular subtypes with distinct etiology, prognosis, and treatment response. This volume will familiarize the reader with the critical signaling pathways and oncogenic drivers for HNC. It will outline the differences between HPV-positive and HPV-negative disease, and how these differences affect treatment choice and outcome. The book will emphasize developments in the past five years, including the growing understanding of the genomic and epigenomic features of the disease based on analysis of next generation sequencing (NGS) data, and timely topics such as the analysis of HNC stem cell populations, non-coding mRNAs, and inflammatory response. It will address exciting new therapeutic approaches such as the use of immunotherapies to treat HNC patients. Overall, the book will provide the reader with current understanding of the biology and treatment of the disease, and describe timely questions that will guide future research aimed at controlling and curing this disease.
650 0 $a Cancer research. $3 1253664
650 0 $a Oncology . $3 1253469
650 0 $a Proteins . $3 1253493
650 1 4 $a Cancer Research. $3 668358
650 2 4 $a Oncology. $3 593951
650 2 4 $a Protein Science. $3 782127
700 1 $a Burtness, Barbara. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1207786
700 1 $a Golemis, Erica A. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1207787
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319787619
776 0 8 $i Printed edition: $z 9783319787633
776 0 8 $i Printed edition: $z 9783030087791
830 0 $a Current Cancer Research, $x 2199-2584 $3 1257028
856 4 0 $u https://doi.org/10.1007/978-3-319-78762-6
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)